Health-related quality of life and health utilities in insulin-treated type 2 diabetes: the impact of related comorbidities/complications.
John N YfantopoulosAthanasios ChantzarasPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2020)
The deleterious impact of comorbidities on insulin-dependent T2DM subjects' HRQoL has been confirmed and clinicians should adapt the priorities of disease management accordingly. The derived health utility estimates may be valuable for conducting economic evaluations of interventions in the area of T2DM when data are not available.